AI assistant
AUDIOEYE INC — Director's Dealing 2021
Feb 23, 2021
33790_dirs_2021-02-22_22351afa-4db4-45e2-a692-5840cf3343af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AUDIOEYE INC (AEYE)
CIK: 0001362190
Period of Report: 2021-01-15
Reporting Person: Sero Capital LLC (Director, See Remarks, 10% Owner)
Reporting Person: Moradi David (Director, See Remarks, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-15 | Common Stock | F | 15651 | $23.86 | Disposed | 334935 | Direct |
| 2021-02-18 | Common Stock | X | 4000 | $6.25 | Acquired | 338935 | Direct |
| 2021-02-18 | Common Stock | S | 600 | $41.65 | Disposed | 338335 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-18 | Warrant (right to buy) | $6.25 | X | 4000 | Disposed | 2021-04-19 | Common Stock (4000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2731265 | Indirect |
Footnotes
F1: Number of Shares withheld to cover withholding taxes associated with with the vesting of 55,000 shares of common stock subject to a performance share award previously granted to David Moradi.
F2: Securities of the Issuer held directly by David Moradi.
F3: On February 18, 2021, the reporting person exercised a warrant to purchase 4,000 shares of AudioeEye, Inc. common stock for $6.25 a share. The reporting person paid the exercise priceon a cashless basis, resulting in AudioeEye, Inc.'s withholding of 600 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 3,400 shares.
F4: Securities of the Issuer held directly by Sero Capital LLC ("Sero Capital"). David Moradi is the Managing Partner of Sero Capital and may be deemed to direct all voting and investment decisions made by Sero Capital.
F5: Pursuant to Instruction 4(c)(iii), this column is left blank.